Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

Nikola pushes shareholder meet again as it seeks nod for key proposal

Fed lending to banks eases a bit in latest week

DeSantis rakes in $20m after wobbly start to 2024 White House run

DeSantis raised $20 million in second quarter, campaign says

US labor agency sues Starbucks over treatment of Seattle workers

French government paints a rosy picture for tourism despite unrest over the police killing of a teen

Market surveys show Wall Street expected less hawkish Fed outlook

US SEC to vote on 'swing pricing,' private investment reporting

Levi Strauss trims annual profit forecast on higher costs, slowing wholesale trends

New Zealand central bank to hold rates in July and for rest of 2023: Reuters poll